Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 15 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Keyword is Bone Morphogenetic Proteins  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Vakalopoulou S., Christoulas D., Paschou S. A., Papatheodorou A., Garipidou V., et al. (2018).  The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.. Haemophilia. 24(2), 316-322.
Anastasilakis, A. D., Polyzos S. A., & Toulis K. A. (2011).  Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.. Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
Anastasilakis, A. D., Polyzos S. A., Tsoli M., Papatheodorou A., Kokkoris P., Kaltsas G., et al. (2017).  Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity.. Metabolism. 71, 198-201.
Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Bisbinas I., Gerou S., & Makras P. (2013).  Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.. J Clin Endocrinol Metab. 98(8), 3206-12.
Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Saridakis Z. G., Digkas D., Bisbinas I., et al. (2015).  Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.. Osteoporos Int. 26(10), 2521-7.
F
Foo, J-P., Polyzos S. A., Anastasilakis A. D., Chou S., & Mantzoros C. S. (2014).  The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.. J Clin Endocrinol Metab. 99(11), E2252-8.
K
Kanakaris, N. K., Petsatodis G., Tagil M., & Giannoudis P. V. (2009).  Is there a role for bone morphogenetic proteins in osteoporotic fractures?. Injury. 40 Suppl 3, S21-6.
Klontzas, M. E., Kenanidis E. I., MacFarlane R. J., Michail T., Potoupnis M. E., Heliotis M., et al. (2016).  Investigational drugs for fracture healing: preclinical & clinical data.. Expert Opin Investig Drugs. 25(5), 585-96.
P
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2013).  Serum sclerostin levels following treatment with parathyroid hormone.. J Endocrinol Invest. 36(4), 280.
Polyzos, S. A., Anastasilakis A. D., Bratengeier C., Woloszczuk W., Papatheodorou A., & Terpos E. (2012).  Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.. Osteoporos Int. 23(3), 1171-6.
Pyrpasopoulou, A., Kotoula V., Cheva A., Hytiroglou P., Nikolakaki E., Magras I. N., et al. (2004).  Bone morphogenetic protein expression in newborn rat kidneys after prenatal exposure to radiofrequency radiation.. Bioelectromagnetics. 25(3), 216-27.
S
Sakellariou, G. T., Iliopoulos A., Konsta M., Kenanidis E., Potoupnis M., Tsiridis E., et al. (2017).  Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters.. Joint Bone Spine. 84(3), 309-315.
Sakellariou, G. T., Anastasilakis A. D., Bisbinas I., Oikonomou D., Gerou S., Polyzos S. A., et al. (2015).  Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.. Rheumatology (Oxford). 54(5), 908-14.
V
Voskaridou, E., Christoulas D., Plata E., Bratengeier C., Anastasilakis A. D., Komninaka V., et al. (2012).  High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.. Horm Metab Res. 44(12), 909-13.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές